New GLP-1 Analog GZR18 Delivers Significant Weight Loss in Early Trials

GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trial. Authors: Ji L, Gao L, Dong R, Yuan M, Zhao D, Pang S, Zhao J, Zhao L, Chen W Journal: Cell reports.…